Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...
CMS has been dedicated to strengthening Medicaid and CHIP by helping eligible people more easily enroll and keep their ...
The Centers for Medicare & Medicaid Services Jan. 13 released its standards for the health insurance marketplaces for 2026, ...
This explainer defines Medicaid work requirements, updates their current status at the federal and state levels, and ...
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...
The Centers for Medicare & Medicaid Services (CMS) has issued the Calendar Year (CY) 2026 Advance Notice, proposing updates to payment policies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback